Literature DB >> 25457251

A preliminary study on surgery for hepatocellular carcinoma patients with portal hypertension.

Yun-Fei Duan1, Xiao-Dong Li2, Dong-Lin Sun1, Xue-Min Chen1, Yong An1, Feng Zhu3.   

Abstract

BACKGROUND: To assess the effects of various operations for hepatocellular carcinoma with portal hypertension (PH).
METHODS: Data regarding 78 patients with resectable liver cancer with PH were analyzed. Patients were divided into 3 groups: A (splenic artery ligation), B (in situ splenectomy), and C (in situ splenectomy + pericardial devascularization).
RESULTS: White blood cell and platelet counts in the 3 groups increased significantly after surgery. Postoperative portal pressure was not significantly lower than preoperative portal pressure in Group A, while it was significantly lower in B. In Group C, the portal pressure after splenectomy was significantly lower than that before the operation, but not again after pericardial devascularization. The 1-, 2-, and 3-year survival rates of all the patients were 89.7%, 64.1%, and 46.1%, respectively.
CONCLUSIONS: PH is not an absolute contraindication to liver resection in Child-Pugh class B cirrhotic patients. The combined surgery for hepatocellular carcinoma patients with PH is a safe choice.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; Hepatocellular carcinoma; Portal hypertension; Surgery

Mesh:

Year:  2014        PMID: 25457251     DOI: 10.1016/j.amjsurg.2014.08.022

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

Review 1.  Liver surgery in cirrhosis and portal hypertension.

Authors:  Christina Hackl; Hans J Schlitt; Philipp Renner; Sven A Lang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

2.  Clinical value of liver and spleen shear wave velocity in predicting the prognosis of patients with portal hypertension.

Authors:  Yan Zhang; Da-Feng Mao; Mei-Wu Zhang; Xiao-Xiang Fan
Journal:  World J Gastroenterol       Date:  2017-12-07       Impact factor: 5.742

3.  Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT).

Authors:  Kayvan Mohkam; Michel Rayar; Jean-Philippe Adam; Fabrice Muscari; Agnès Rode; Philippe Merle; Pierre Pradat; Stéphanie Bauler; Isabelle Delfour; Laurence Chiche; Christian Ducerf; Karim Boudjema; Mickaël Lesurtel; Christophe Laurent; Jean-Yves Mabrut
Journal:  BMC Cancer       Date:  2018-08-23       Impact factor: 4.430

4.  Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study.

Authors:  Youliang Pei; Zhanguo Zhang; Abdoul-Aziz Mba'nbo-Koumpa; Xiaoping Chen; Wanguang Zhang
Journal:  Hepatol Res       Date:  2019-01-04       Impact factor: 4.288

5.  Clinical application of combined laparoscopic surgery in the treatment of primary hepatocellular carcinoma with portal hypertension: a report of 16 cases.

Authors:  Peng Guo; Shengtao Liao; Jianwei Li; Shuguo Zheng
Journal:  Transl Cancer Res       Date:  2019-02       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.